Vaccine
Sanofi Invests $175M in J&J’s Advanced E. coli Vaccine, Amplifying its Vaccine Development Efforts
Sanofi is making a strategic move by investing $175 million in Johnson & Johnson’s late-phase E. coli vaccine, ExPEC9V. As ...
Arcturus reports positive results for sa-mRNA COVID boosters in phase 1/2 trial
Amid a shrinking COVID-19 vaccine market, Arcturus Therapeutics is forging ahead with its mRNA candidate, revealing promising early data demonstrating ...
Sanofi teams up with Ice-T to scare people into getting flu shots
Sanofi is breaking the mold with a bold and captivating campaign aimed at alerting older adults to the perils of ...
Moderna to cut down COVID booster production amid low demand: Reuters reports
While the FDA and the Centers for Disease Control and Prevention (CDC) have given their green light to updated COVID ...
SK Bioscience invests $85M on a 7% share in the vaccine manufacturer, Novavax, to keep it afloat
Following its setback during the pandemic phase of COVID-19 with a delayed vaccine, Novavax is now aiming for recovery in ...
Pfizer Unveils Promising GBS Maternal Vaccine in New England Journal of Medicine
Source – Pfizer On July 19, Pfizer released promising data from a Phase II study of their GBS6 vaccine candidate, ...
The FDA expedites the development of GSK’s vaccine for gonorrhea
Source – GSK GSK’s vaccine for gonorrhea has received a fast-track designation from the FDA, signaling its potential to combat ...
